Vancomycin use in a University Medical Center: Comparison with hospital infection control practices advisory committee guidelines

Infection Control and Hospital Epidemiology

Volumn 17, Issue 6, 1996, Pages 356-359

  Evans, Martin E ^a   Kortas, Kenneth J ^b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; DECISION MAKING; DRUG USE; HOSPITAL BED CAPACITY; HUMAN; INFECTION CONTROL; PRACTICE GUIDELINE; PROSPECTIVE STUDY; STANDARD; STAPHYLOCOCCUS INFECTION; UNITED STATES; UNIVERSITY HOSPITAL;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; DECISION MAKING; DRUG UTILIZATION REVIEW; HOSPITAL BED CAPACITY, 300 TO 499; HOSPITALS, UNIVERSITY; HUMANS; INFECTION CONTROL; KENTUCKY; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; UNITED STATES; VANCOMYCIN;

EID: 0030158191     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141133     Document Type: Review

References (13)

1. Murray BE. Editorial response: what can we do about vancomycin-resistant enterococci? Clin Infect Dis 1995;20:1134-1136.
2. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126-1133.
3. Centers for Disease Control and Prevention. Addressing emerging infectious disease threats: a prevention strategy for the United States (executive summary). MMWR 1994;43(No. RR-5):1-18.
4. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750-755.
5. Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Preventing the spread of vancomycin resistance: a report from the Hospital Infection Control Practices Advisory Committee prepared by the subcommittee on prevention and control of antimicrobial-resistant microorganisms in hospitals. Infect Control Hosp Epidemiol 1995;16:105-113.
6. Centers for Disease Control and Prevention. Drug-resistant Streptococcus pneumoniae - Kentucky and Tennessee, 1993. MMWR 1994;43:23-25.
7. Smith SM, Mangia A, Eng RHK, Ruggeri P, Cytryn A, Tecson-Tumang F. Clindamycin for colonization and infection by methicillin-resistant Staphylococcus aureus. Infection 1988;16:95-97.
8. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim-sulfamethoxazole compared to vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 1992;117:390-398.
9. Jemni L, Hmouda H, Letaief A. Efficacy of trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus: a report from Tunisia. Clin Infect Dis 1994;19:202-203.
10. Brumfitt W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med 1989;320:1188-1196.
11. Daum TE, Schaberg DR, Terpenning MS, Scottile WS, Kauffman CA. Increasing resistance of Staphylococcus aureus to ciprofloxacin. Antimicrob Agents Chemother 1990;34:1862-1863.
12. Irwin DB, Dupuis LL, Prober CG, Tesoro A. The acceptability, stability, and relative bioavailability of an extemporaneous metronidazole suspension. Can J Hosp Pharmacy 1987;40:42-46.
13. Muder RA, Brennen C, Wagener MM, et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med 1991;114:107-112.